Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones
Femasys’ stock surge on Oct. 16 mirrors growing investor interest in its reproductive healthcare pipeline. The company’s FemaSeed™ technology is designed to boost pregnancy rates by delivering sperm directly into the fallopian